We will be contrasting the differences between Protagonist Therapeutics Inc. (NASDAQ:PTGX) and INSYS Therapeutics Inc. (NASDAQ:INSY) as far as profitability, analyst recommendations, institutional ownership, risk, dividends, earnings and valuation are concerned. The two businesses are rivals in the Biotechnology industry.
Valuation and Earnings
In table 1 we can see Protagonist Therapeutics Inc. and INSYS Therapeutics Inc.’s top-line revenue, earnings per share and valuation.
Table 2 shows the net margins, return on assets and return on equity of the two firms.
The Current Ratio and a Quick Ratio of Protagonist Therapeutics Inc. are 6.1 and 6.1. Competitively, INSYS Therapeutics Inc. has 0.7 and 0.6 for Current and Quick Ratio. Protagonist Therapeutics Inc.’s better ability to pay short and long-term obligations than INSYS Therapeutics Inc.
The following table given below contains the ratings and recommendations for Protagonist Therapeutics Inc. and INSYS